Sign inGet started

Schemel Donald Robert

Insider CIK 1652854 · SNBP Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PBLA Panbela Therapeutics, Inc. A Award deriv2023-03-272023-03-298,333— $08,333SEC↗
PBLA Panbela Therapeutics, Inc. P Buy deriv2022-10-042022-10-06300,000— $0300,000SEC↗
PBLA Panbela Therapeutics, Inc. P Buy2022-10-042022-10-06200,000— $0482,654SEC↗
PBLA Panbela Therapeutics, Inc. A Award deriv2021-05-252021-05-2712,368— $012,368SEC↗
PBLA Panbela Therapeutics, Inc. A Award2021-05-252021-05-274,316— $096,619SEC↗
PBLA Panbela Therapeutics, Inc. A Award2020-12-012020-12-032,875— $092,303SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2020-06-242020-06-2613,700— $013,700SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2019-05-212019-05-2327,000— $027,000SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2019-05-212019-05-236,800— $06,800SEC↗
SNBP Sun BioPharma, Inc. G Gift deriv2018-09-272018-10-0111,767— $011,767SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2016-12-122016-12-14208,000— $0208,000SEC↗
SNBP Sun BioPharma, Inc. S Sale2016-11-142016-12-017,000$1.43 $10.0K2,826,548SEC↗